The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Tumor Microvessel Density as a Predictor of Recurrence After Resection of Hepatocellular Carcinoma: A Prospective Study
Abstract
PURPOSE: This study prospectively evaluated the correlation of tumor microvessel density (MVD) with clinicopathologic features and postoperative recurrence in patients undergoing resection of hepatocellular carcinoma (HCC). PATIENTS AND METHODS: Tumor MVD was assessed in 100 patients with resection of HCC using a computer image analyzer after immunostaining for CD34 (MVD-CD34) and von Willebrand factor (MVD-vWF), respectively. Patients were prospectively followed for recurrence. RESULTS: Mean tumor MVD-CD34 (236/0.74 mm 2) was higher than mean tumor MVD-vWF (87/0.74 mm 2) (P < .001). By multiple regression analysis, tumor size was the only pathologic feature significantly related to tumor MVD-CD34. The median MVD-CD34 was 316/0.74 mm 2 in HCCs ≤ 5 cm (n = 46) and 146/0.74 mm 2 in HCCs more than 5 cm (n = 54) (P < .001). Among patients with HCCs ≤ 5 cm, those with higher than median MVD-CD34 had worse disease-free survival (at 3 years, 13%) than those with a lower MVD-CD34 (at 3 year, 74%) (P = .002). Multivariate analysis showed that tumor MVD-CD34 was the only significant factor predictive of disease-free survival in patients with HCC ≤ 5 cm. For HCCs more than 5 cm, MVD-CD34 did not have a significant prognostic influence. MVD-vWF did not have a significant prognostic influence on disease-free survival in either HCCs ≤ 5 cm or more than 5 cm. CONCLUSION: This study shows that a high MVD-CD34 was predictive of early postresection recurrence in patients with HCCs ≤ 5 cm and, therefore, may be a novel prognostic marker in this subset of patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
What Is the Evidence That Tumors Are Angiogenesis Dependent?
Folkman, J. (1990) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/82.1.4 · Cited by 4,531
Primary carcinoma of the liver.A study of 100 cases among 48,900 necropsies
Edmondson, H. A., & Steiner, P. E. (1954) · Cancer · doi:10.1002/1097-0142(195405)7:3<462::aid-cncr2820070308>3.0.co;2-e · Cited by 2,772
Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
Liotta, L. A., Steeg, P. S., & Stetler-Stevenson, W. G. (1991) · Cell · doi:10.1016/0092-8674(91)90642-c · Cited by 2,720
Clinical Applications of Research on Angiogenesis
Folkman, J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512283332608 · Cited by 2,264
Weidner, N., Folkman, J., Pozza, F., Bevilacqua, P., Allred, E. N., Moore, D. H., Meli, S., & Gasparini, G. (1992) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/84.24.1875 · Cited by 1,775
(1985) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60946-x · Cited by 1,071
Intratumor microvessel density as a prognostic factor in cancer.
Weidner, N. (1995) · PubMed Central · Cited by 866
Takayama, T., Sekine, T., Makuuchi, M., Yamasaki, S., Kosuge, T., Yamamoto, J., Shimada, K., Sakamoto, M., Hirohashi, S., Ohashi, Y., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02654-4 · Cited by 847
Tung-Ping Poon, R., Fan, S.-T., & Wong, J. (2000) · Annals of Surgery · doi:10.1097/00000658-200007000-00003 · Cited by 811
Self-citationLiotta, L. A., Kleinerman, J. I., & Saidel, G. M. (1974) · PubMed · Cited by 766
Poon, R. T.-P., Fan, S.-T., Ng, I. O.-L., Lo, C.-M., Liu, C.-L., & Wong, J. (2000) · Cancer · doi:10.1002/1097-0142(20000801)89:3<500::aid-cncr4>3.0.co;2-o · Cited by 729
Self-citationLiver Transplantation for Hepatocellular Carcinoma
Bismuth, H., Majno, P., & Adam, R. (1999) · Seminars in Liver Disease · doi:10.1055/s-2007-1007120 · Cited by 561
Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia
Padró, T., Ruiz, S., Bieker, R., Bürger, H., Steins, M., Kienast, J., Büchner, T., Berdel, W. E., & Mesters, R. M. (2000) · Blood · doi:10.1182/blood.v95.8.2637 · Cited by 476
Lau, W., Leung, T., Ho, S., Chan, M., Machin, D., Lau, J., Chan, A., Yeo, W., Mok, T., Yu, S., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)06475-7 · Cited by 409
Ebara, M., Ohto, M., Shinagawa, T., Sugiura, N., Kimura, K., Matsutani, S., Morita, M., Saisho, H., Tsuchiya, Y., & Okuda, K. (1986) · Gastroenterology · doi:10.1016/0016-5085(86)90923-6 · Cited by 394
Nagy, J. A., Brown, L. F., Senger, D. R., Lanir, N., Van De Water, L., Dvorak, A. M., & Dvorak, H. F. (1989) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(89)90004-8 · Cited by 380
Ikeda, K., Arase, Y., Saitoh, S., Kobayashi, M., Suzuki, Y., Suzuki, F., Tsubota, A., Chayama, K., Murashima, N., & Kumada, H. (2000) · Hepatology · doi:10.1053/jhep.2000.9409 · Cited by 354
El-Assal, O. N., Yamanoi, A., Soda, Y., Yamaguchi, M., Igarashi, M., Yamamoto, A., Nabika, T., & Nagasue, N. (1998) · Hepatology · doi:10.1002/hep.510270613 · Cited by 326
Tumor angiogenesis as a predictor of recurrence in gastric carcinoma.
Maeda, K., Chung, Y. S., Takatsuka, S., Ogawa, Y., Sawada, T., Yamashita, Y., Onoda, N., Kato, Y., Nitta, A., & Arimoto, Y. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.2.477 · Cited by 246
Postoperative Recurrence of Hepatocellular Carcinoma
NAGAO, T., INOUE, S., YOSHIMI, F., SODEYAMA, M., OMORI, Y., MIZUTA, T., KAWANO, N., & MORIOKA, Y. (1990) · Annals of Surgery · doi:10.1097/00000658-199001000-00005 · Cited by 235
Schlingemann, R. O., Rietveld, F. J. R., de Waal, R. M. W., Bradley, N. J., Skene, A., Davies, A. J., Greaves, M. F., Denekamp, J., & Ruiter, D. J. (1990) · PubMed · Cited by 196
Vacca, A., Ribatti, D., Ruco, L., Giacchetta, F., Nico, B., Quondamatteo, F., Ria, R., Iurlaro, M., & Dammacco, F. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690154 · Cited by 148
Microvessel density of hepatocellular carcinoma: its relationship with prognosis
Sun, H., Tang, Z., Li, X., Zhou, Y., Sun, B.-R., & Ma, Z. (1999) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s004320050296 · Cited by 118
Wang, L., Tang, Z., Qin, L., Wu, X., Sun, H., Xue, Q., & Ye, S. (2000) · Hepatology · doi:10.1053/jhep.2000.8525 · Cited by 118
Enhanced CD34 expression of sinusaid‐like vascular endothelial cells in hepatocellular carcinoma
Cui, S., Hano, H., Sakata, A., Harada, T., Liu, T., TAKAI, S., & Ushigomey, S. (1996) · Pathology International · doi:10.1111/j.1440-1827.1996.tb03544.x · Cited by 94
Mazzanti, R., Messerini, L., Monsacchi, L., Buzzelli, G., Zignego, A. L., Foschi, M., Monti, M., Laffi, G., Morbidelli, L., Fantappiè, O., et al. (1997) · Hepatology · doi:10.1002/hep.510250142 · Cited by 83
Ruck, P., Xiao, J., & KAISERLING, E. (1995) · PubMed · Cited by 78
Durable Clinical Response of Refractory Hepatocellular Carcinoma to Orally Administered Thalidomide
Patt, Y. Z., Hassan, M. M., Lozano, R. D., Ellis, L. M., Peterson, J. A., & Waugh, K. A. (2000) · American Journal of Clinical Oncology · doi:10.1097/00000421-200006000-00023 · Cited by 70
An immunohistochemical and ultrastructural study of the sinusoids of hepatocellular carcinoma
Haratake, J., & Scheuer, P. J. (1990) · Cancer · doi:10.1002/1097-0142(19900501)65:9<1985::aid-cncr2820650918>3.0.co;2-c · Cited by 68
Niedergethmann, M., Hildenbrand, R., Wolf, G., Verbeke, C. S., Richter, A., & Post, S. (2000) · International Journal of Gastrointestinal Cancer · doi:10.1385/ijgc:28:1:31 · Cited by 65
Xia, J., Yang, B., Tang, Z., Sun, F.-X., Xue, Q., & Gao, D. (1997) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01240121 · Cited by 41
Terada, T., & Nakanuma, Y. (1995) · Histopathology · doi:10.1111/j.1365-2559.1995.tb01523.x · Cited by 40
Vascular enumeration as a significant prognosticator for invasive breast carcinoma.
Fernández‐Aceñero, M. J., González, J., Gallego, M., & Ballesteros, P. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.5.1684 · Cited by 39
Ruck, P., Xiao, J., & KAISERLING, E. (1995) · Histopathology · doi:10.1111/j.1365-2559.1995.tb00253.x · Cited by 25
Pathophysiology of ischaemia-reperfusion injury
Carden, D. L., & Granger, D. N. (2000) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(200002)190:3 · Cited by 5
Cited by
Liu, L., Cao, Y., Chen, C., Zhang, X., McNabola, A., Wilkie, D., Wilhelm, S., Lynch, M., & Carter, C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1377 · Cited by 1,536
Gao, Q., Qiu, S.-J., Fan, J., Zhou, J., Wang, X.-Y., Xiao, Y.-S., Xu, Y., Li, Y.-W., & Tang, Z.-Y. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.4565 · Cited by 1,110
Cheng, A.-L., Kang, Y.-K., Lin, D.-Y., Park, J.-W., Kudo, M., Qin, S., Chung, H.-C., Song, X., Xu, J., Poggi, G., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.8372 · Cited by 777
Zhang, J.-P., Yan, J., Xu, J., Pang, X.-H., Chen, M.-S., Li, L., Wu, C., Li, S.-P., & Zheng, L. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.12.033 · Cited by 535
Rugo, H. S., Herbst, R. S., Liu, G., Park, J. W., Kies, M. S., Steinfeldt, H. M., Pithavala, Y. K., Reich, S. D., Freddo, J. L., & Wilding, G. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.192 · Cited by 486
Metadata
- Authors
- Poon, R. T.-P., Ng, I. O.-L., Lau, C., Yu, W.-C., Yang, Z.-F., Fan, S.-T., & Wong, J.
- Venue
- Journal of Clinical Oncology
- Published
- 2002-04-01
- Volume
- 20
- Issue
- 7
- Pages
- 1775-1785
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2047679549
- Cited by
- 285
- References
- 35
- FWCI
- 6.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.